© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Butenafine Hydrochloride appears in industry labs and pharmacies as a synthetic antifungal compound. Its main purpose focuses on the treatment of common fungal skin infections, including athlete’s foot, jock itch, and ringworm. As a hydrochloride salt, this substance stands out because it brings both clinical reliability and chemical stability, making it a regular feature in the world of topical medications and raw chemical sourcing. People who have struggled with persistent fungal infections at home or in healthcare settings often recognize how such a compound can transform the treatment landscape just by being consistent and effective.
The molecular formula for Butenafine Hydrochloride reads C23H27N•HCl. Structurally, this compound is classified as a benzylamine derivative. On a microscopic level, the molecule features a well-built, stable crystal lattice, making it suitable for storage and transport. Analyzing the chemical blueprint, the arrangement allows for solid antifungal activity by disrupting fungal cell membranes and halting the spread of the infection. This robust chemistry means accuracy is crucial in synthesis. A minor impurity can alter its mode of action and safety profile. Every time a batch is tested, pharmaceutical manufacturers look for these details—consistency in structure directly affects outcomes for real people relying on it for relief.
Butenafine Hydrochloride usually arrives as a white or almost white crystalline powder. Individuals handling the material note a soft texture, with a slightly stubborn tendency to clump unless kept dry. At room temperature, it remains stable and non-volatile. In applications, laboratories depend on its precise melting point, which ranges from 231°C to 234°C. Specific gravity sits at approximately 1.06, distinguishing it from bulkier or lighter powders. It dissolves well in methanol, ethanol, and dimethyl sulfoxide, but in water, solubility drops, creating challenges for formulations that need rapid skin absorption. Every pharmacist who develops an ointment or cream can tell you how the solubility question drives the choice of excipients and solvents, and Butenafine Hydrochloride tests that formulation skill.
This compound circulates mainly as a fine, white powder, but practitioners may encounter it as crystalline flakes or grains, especially from suppliers focusing on raw material sales. Solution forms—typically prepared in alcohol-based carriers—show up in specialized clinical pharmacies aiming for higher absorption rates or custom dosages. During transport, suppliers often choose material-grade polyethylene or glass bottles, as the powder holds up well under moderate temperature and pressure shifts as long as moisture stays out. Any user who has spilled a raw sample on a lab bench realizes its persistence—It clings, resists blowing away, sometimes leaves a faint odor but doesn’t cake into hard masses the way some hygroscopic chemicals do.
On the regulatory side, Butenafine Hydrochloride carries the HS Code 2933490090, slotting it into a narrow group of pharmaceutical chemical products. Suppliers list particle size, purity—often 98.0% or higher—and bulk density in every technical data sheet. Larger shipments usually come in 25-kilogram fiber drums, carefully double-lined to keep the interior dry. Packaging matters because exposure to ambient moisture over the shipping journey can compromise not only the texture but also the chemical stability of the entire batch. That’s a real concern for intermediaries handling pharmaceuticals in hot, humid ports or depots. In daily operations, blenders and pharmacists appreciate the predictability of specification: one deviation in density or crystal habit, and mixing machines need recalibration.
Butenafine Hydrochloride remains classified as a pharmaceutical ingredient, so its hazards fit the typical lab-grade chemical profile—mainly irritation risks if inhaled as powder or handled without gloves. The material isn’t classified as especially hazardous for regular chemical handling, and thus doesn’t require the most extreme protective gear seen in other classes. Spills get swept up with care; lab staff understand the importance of eye protection, dust minimization, and prompt washing after direct contact. Storage demands a cool, dry, dark location, far from moisture and incompatible compounds. Real-life experience says that, despite the official recommendations, labs sometimes store it alongside other antifungals, but always segregate it from acids, bases, and powerful oxidizers. The material has a shelf life stretching at least two years—longer if kept under optimal conditions of less than 30°C and relative humidity below 40%. Fire hazards stay low under normal circumstances. Only if large amounts catch fire in an industrial accident does the risk rise, with chlorinated smoke produced on combustion.
From a functional perspective, Butenafine Hydrochloride’s performance comes down to its interactions with biological membranes. In practice, doctors notice that topical creams containing this compound deliver fast results on athlete’s foot—sometimes clearing up symptoms in just a few days. Lab studies support these observations, showing that Butenafine Hydrochloride penetrates skin layers effectively, targets ergosterol synthesis, and leaves healthy human skin cells largely unharmed. Real cases in dermatology clinics have confirmed that, for many patients, it operates comparably to better-known agents like terbinafine, but often at a lower risk of irritation. In pharmaceutical development, the challenge comes from keeping the molecule both active and pleasant on the skin, so formulators add stabilizers, moisturizers, and a host of excipients to address stinging, dryness, or residue.
For buyers, sourcing Butenafine Hydrochloride as a raw material brings its own headaches and rewards. The global active pharmaceutical ingredient market shows regular fluctuations in price, driven by seasonal demand, production at high-volume sites (mainly in Asia), and international shipping reliability. Responsible procurement teams look for GMP or ISO certifications, documented supply chains, and reliable third-party testing, since impurities can spell disaster for a new drug launch. In some real procurement scenarios, rejections happen due to minor deviations in color or odor, even when other specs look perfect, causing delay in time-sensitive product rollouts. Labs with tighter budgets sometimes accept off-spec batches, using them for research rather than final production.
Every statistic listed for Butenafine Hydrochloride—density, color, melting point, and solubility—feeds directly into its use experience. For end users, this plays out as comfort and relief in a topical cream. For chemists and pharmacists, reliability means streamlined formulation, batch consistency, and regulatory approval with less hassle. For those working in hot, humid climates, minor packaging failures can shift the entire game, demanding innovative solutions like moisture-absorbing liners and hidden desiccants buried deep in a drum. For raw material buyers, the certainty of a known HS code, stable specification sheet, and predictable packaging size keeps budgets and lead-times in line, especially in a world where international supply disruptions have become more common.
The industry continues to explore better methods for making, packaging, and formulating Butenafine Hydrochloride. There’s space for improvement in eco-friendly packaging, moisture-control technology, and standardized, automated blending at the factory scale. Some innovative manufacturers experiment with encapsulated powder formats, aiming to deliver the raw material in more user-friendly forms, reducing airborne dust and storage risks. On the safety side, continuous training for staff dealing with all forms of the material, from raw crystals to solution, minimizes incidents. Real progress happens in local labs as well as at big industrial sites, driven by users who match safety with practicality day in and day out.
